HB-1614

N/A

Report date: 2025/10/21 14:45:47
NME

Base Information

Drug NameHB-1614
Drug Alias NameHB-1614
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyaluronic acid modulators
TargetsHyaluronic acid
Therapy Area/IndicationsLung Diseases, InterstitialPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHalo Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesHalo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsLung Diseases, InterstitialPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A